Diet high in fat and sucrose induces rapid onset of obesity-related metabolic syndrome partly through rapid response of genes involved in lipogenesis, insulin signalling and inflammation in mice

Diabetology and Metabolic Syndrome

Volumn 4, Issue 1, 2012, Pages

  Yang, Zhi Hong ^a   Miyahara, Hiroko ^a   Takeo, Jiro ^a   Katayama, Masashi ^a  

^a NIPPON SUISAN KAISHA LTD   (Japan)

Author keywords

Hepatosteatosis; High fat high sucrose diet; Inflammation; Insulin signalling

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CHOLESTEROL; COMPLEMENTARY DNA; FAT; INSULIN; MESSENGER RNA; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; FATTY LIVER; FOOD INTAKE; GENE EXPRESSION; HYPERINSULINEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; LIPID DIET; LIPOGENESIS; LIVER; LIVER WEIGHT; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUGAR INTAKE; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

EID: 84863208496     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-4-32     Document Type: Article

References (48)

1. The epidemiology of obesity. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM, Gastroenterology 2007 132 2087 2102 10.1053/j.gastro.2007.03.052 17498505 (Pubitemid 46693751)
2. The obesity epidemic: challenges, health initiatives, and implications for gastroenterologists. Hurt RT, Kulisek C, Buchanan LA, McClave SA, Gastroenterol Hepatol NY 2010 6 780 792
3. Influences of weight loss on long-term diabetes outcomes. Aucott LS, Proc Nutr Soc 2008 67 54 59 10.1017/S0029665108006022 18234132 (Pubitemid 351185357)
4. The metabolic syndrome: prevalence in worldwide populations. Cameron AJ, Shaw JE, Zimmet PZ, Endocrinol Metab Clin North Am 2004 33 351 375 10.1016/j.ecl.2004.03.005 15158523 (Pubitemid 38680634)
5. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM, J Am Coll Cardiol 2007 49 403 414 10.1016/j.jacc.2006.09.032 17258085 (Pubitemid 46135879)
6. Reversibility of chronic experimental syndrome X by diet modification. Roberts CK, Vaziri ND, Liang KH, Barnard RJ, Hypertension 2001 37 1323 1328 10.1161/01.HYP.37.5.1323 11358948 (Pubitemid 34163589)
7. Effects of a high-fat, sucrose diet on serum insulin and related atherosclerotic risk factors in rats. Barnard RJ, Faria DJ, Menges JE, Martin DA, Atherosclerosis 1993 100 229 236 10.1016/0021-9150(93)90209-D 8357355 (Pubitemid 23183722)
8. The effect of excess dietary sucrose on growth, blood pressure, and metabolism in developing Sprague-Dawley rats. Hulman S, Falkner B, Pediatr Res 1994 36 95 101 7936845 (Pubitemid 24185195)
9. Current therapeutic strategies in non-alcoholic fatty liver disease. Dowman JK, Armstrong MJ, Tomlinson JW, Newsome PN, Diabetes Obes Metab 2011 13 692 702 10.1111/j.1463-1326.2011.01403.x 21449949
10. Adipose tissue macrophages: their role in adipose tissue remodeling. Suganami T, Ogawa Y, J Leukoc Biol 2010 88 33 39 10.1189/jlb.0210072 20360405
11. Diet-induced type II diabetes in C57BL/6J mice. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN, Diabetes 1988 37 1163 1167 10.2337/diabetes.37.9.1163 3044882 (Pubitemid 19035045)
12. Variation in type 2 diabetes-related traits in mouse strains susceptible to diet-induced obesity. Rossmeisl M, Rim JS, Koza RA, Kozak LP, Diabetes 2003 52 1958 1966 10.2337/diabetes.52.8.1958 12882911 (Pubitemid 36919787)
13. A simple method for the isolation and purification of total lipides from animal tissues. Folch J, Lees M, Stanley GHS, J Biol Chem 1956 226 497 509
14. Lipoprotein lipase: structure, function, regulation, and role in disease. Mead JR, Irvine SA, Ramji DP, J Mol Med 2002 80 753 769 10.1007/s00109-002- 0384-9 12483461 (Pubitemid 35478124)
15. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, Lutz EP, Kako Y, Velez-Carrasco W, Goldberg IJ, Breslow JL, Shulman GI, Proc Natl Acad Sci U S A 2001 98 7522 7527 10.1073/pnas.121164498 11390966 (Pubitemid 32567981)
16. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. Horton JD, Goldstein JL, Brown MS, J Clin Invest 2002 109 1125 1131 11994399 (Pubitemid 34496588)
17. Regulation of gene expression by SREBP and SCAP. Edwards PA, Tabor D, Kast HR, Venkateswaran A, Biochim Biophys Acta 2000 1529 103 113 10.1016/S1388-1981(00)00140-2 11111080
18. Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms. Miyazaki M, Dobrzyn A, Man WC, Chu K, Sampath H, Kim HJ, Ntambi JM, J Biol Chem 2004 279 25164 25171 10.1074/jbc.M402781200 15066988 (Pubitemid 38756766)
19. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Dentin R, Girard J, Postic C, Biochimie 2005 87 81 86 10.1016/j.biochi.2004.11.008 15733741 (Pubitemid 40298769)
20. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Apfel R, Benbrook D, Lernhardt E, Ortiz MA, Salbert G, Pfahl M, Mol Cell Biol 1994 14 7025 7035 7935418
21. Liver X receptors as integrators of metabolic and inflammatory signaling. Zelcer N, Tontonoz P, J Clin Invest 2006 116 607 614 10.1172/JCI27883 16511593 (Pubitemid 43326865)
22. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdorf DJ, Genes Dev 2000 14 2819 2830 10.1101/gad.844900 11090130
23. Liver X receptor signaling pathways in cardiovascular disease. Tontonoz P, Mangelsdorf DJ, Mol Endocrinol 2003 17 985 993 10.1210/me.2003-0061 12690094 (Pubitemid 36683707)
24. Role of LXRs in control of lipogenesis. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, Lustig KD, Shan B, Genes Dev 2000 14 2831 2838 10.1101/gad.850400 11090131
25. The nuclear receptor LXR is a glucose sensor. Mitro N, Mak PA, Vargas L, Godio C, Hampton E, Molteni V, Kreusch A, Saez E, Nature 2007 445 219 223 10.1038/nature05449 17187055 (Pubitemid 46095727)
26. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Schadinger SE, Bucher NL, Schreiber BM, Farmer SR, Am J Physiol Endocrinol Metab 2005 288 1195 E1205 10.1152/ajpendo.00513.2004 15644454 (Pubitemid 40726807)
27. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Memon RA, Tecott LH, Nonogaki K, Beigneux A, Moser AH, Grunfeld C, Feingold KR, Endocrinology 2000 141 4021 4031 10.1210/en.141.11.4021 11089532
28. Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Rahimian R, Masih-Khan E, Lo M, van Breemen C, McManus BM, Dubé GP, Mol Cell Biochem 2001 224 29 37 10.1023/A:1011927113563 11693197 (Pubitemid 32962649)
29. Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones. Bedoucha M, Atzpodien E, Boelsterli UA, J Hepatol 2001 35 17 23 10.1016/S0168-8278(01)00066-6 11495036 (Pubitemid 32646220)
30. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. Matsusue K, Haluzik M, Lambert G, Yim SH, Gavrilova O, Ward JM, Brewer B, Reitman ML, Gonzalez FJ, J Clin Invest 2003 111 737 747 12618528 (Pubitemid 36278592)
31. Lipid-induced insulin resistance: unravelling the mechanism. Samuel VT, Petersen KF, Shulman GI, Lancet 2010 375 2267 2277 10.1016/S0140-6736(10)60408-4 20609972
32. Diacylglycerol-mediated insulin resistance. Erion DM, Shulman GI, Nat Med 2010 16 400 402 10.1038/nm0410-400 20376053
33. The effect of fructose on renal biology and disease. Johnson RJ, Sanchez-Lozada LG, Nakagawa T, J Am Soc Nephrol 2010 21 2036 2039 10.1681/ASN.2010050506 21115612
34. Fructose, glycemic load, and quantity and quality of carbohydrate in relation to plasma C-peptide concentrations in US women. Wu T, Giovannucci E, Pischon T, Hankinson SE, Ma J, Rifai N, Rimm EB, Am J Clin Nutr 2004 80 1043 1049 15447918
35. Fructose transport and metabolism in adipose tissue of Zucker rats: diminished GLUT5 activity during obesity and insulin resistance. Litherland GJ, Hajduch E, Gould GW, Hundal HS, Mol Cell Biochem 2004 261 23 33 15362482 (Pubitemid 39004513)
36. Hexosamines as mediators of nutrient sensing and regulation in diabetes. McClain DA, J Diabetes Complications 2002 16 72 80 10.1016/S1056-8727(01)00188-X 11872372 (Pubitemid 34168506)
37. Inflammation and insulin resistance. Shoelson SE, Lee J, Goldfine AB, J Clin Invest 2006 116 1793 1801 10.1172/JCI29069 16823477
38. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Maury E, Brichard SM, Mol Cell Endocrinol 2010 314 1 16 10.1016/j.mce.2009.07.031 19682539
39. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW, J Clin Invest 2006 116 115 124 10.1172/JCI24335 16341265 (Pubitemid 43121796)
40. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale FV, Shelton DL, Hébert CC, EMBO J 2000 19 4046 4055 10.1093/emboj/19.15.4046 10921885 (Pubitemid 30608543)
41. The hormone resistin links obesity to diabetes. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA, Nature 2001 409 307 312 10.1038/35053000 11201732 (Pubitemid 32151228)
42. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Rajala MW, Qi Y, Patel HR, Takahashi N, Banerjee R, Pajvani UB, Sinha MK, Gingerich RL, Scherer PE, Ahima RS, Diabetes 2004 53 1671 1679 10.2337/diabetes.53.7.1671 15220189 (Pubitemid 38857023)
43. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. Rajala MW, Obici S, Scherer PE, Rossetti L, J Clin Invest 2003 111 225 230 12531878 (Pubitemid 36105921)
44. Adenovirus-mediated chronic hyper-resistinemia leads to in vivo insulin resistance in normal rats. Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I, Olefsky JM, J Clin Invest 2004 114 224 231 15254589 (Pubitemid 39071627)
45. Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. Biddinger SB, Almind K, Miyazaki M, Kokkotou E, Ntambi JM, Kahn CR, Diabetes 2005 54 1314 1323 10.2337/diabetes.54.5.1314 15855315 (Pubitemid 40586659)
46. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Brown MS, Goldstein JL, Proc Natl Acad Sci U S A 1999 96 11041 11048 10.1073/pnas.96.20.11041 10500120 (Pubitemid 29487324)
47. Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells. Krammer J, Digel M, Ehehalt F, Stremmel W, Füllekrug J, Ehehalt R, Int J Med Sci 2011 8 599 614 22022213
48. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. Coburn CT, Knapp FF, Febbraio M, Beets AL, Silverstein RL, Abumrad NA, J Biol Chem 2000 275 32523 32529 10913136